VOAM
NRXPW

Vertex One Asset Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Vertex One Asset Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$35K Hold
200,000
– – 0.01% 107
2019
Q3 		$34K Buy
+200,000
New +$39K 0.01% 120

Other funds holding NRXPW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Vertex One Asset Management's NRXPW Position: Q4 2019 in Review

Vertex One Asset Management held its NRX Pharmaceuticals Warrant (NRXPW) position steady in Q4 2019 at 200,000 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #107.

Vertex One Asset Management first reported a position in NRXPW in Q3 2019 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold NRXPW as of Q4 2019.

  • Vertex One Asset Management held 200,000 shares of NRX Pharmaceuticals Warrant worth $35K as of Q4 2019.
  • Vertex One Asset Management left its NRX Pharmaceuticals Warrant share count unchanged in Q4 2019.
  • NRX Pharmaceuticals Warrant made up 0.01% of Vertex One Asset Management's portfolio in Q4 2019, its #107 holding.
  • Vertex One Asset Management first reported a position in NRX Pharmaceuticals Warrant in Q3 2019 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2019.

Based on Vertex One Asset Management's 13F filing for Q4 2019, filed 21 Jan 2020.